The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9486, pp. 665 - 675
Phaeochromocytomas are rare neuroendocrine tumours with a highly variable clinical presentation but most commonly presenting with episodes of headaches,...
MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | ADRENAL-SPARING SURGERY | LAPAROSCOPIC ADRENALECTOMY | HEREDITARY PHEOCHROMOCYTOMA | EXTRAADRENAL PHEOCHROMOCYTOMA | MALIGNANT PHEOCHROMOCYTOMA | HIPPEL-LINDAU-DISEASE | CHROMOGRANIN-A | ENDOCRINE NEOPLASIA TYPE-2 | PLASMA METANEPHRINES | Pheochromocytoma - genetics | Pheochromocytoma - diagnosis | Pheochromocytoma - therapy | Humans | Causes of | Care and treatment | Pheochromocytoma | Diagnosis | Risk factors | Pathology | Adrenal glands | Medical treatment | Surgery | Diagnostic tests | Tumors
MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | ADRENAL-SPARING SURGERY | LAPAROSCOPIC ADRENALECTOMY | HEREDITARY PHEOCHROMOCYTOMA | EXTRAADRENAL PHEOCHROMOCYTOMA | MALIGNANT PHEOCHROMOCYTOMA | HIPPEL-LINDAU-DISEASE | CHROMOGRANIN-A | ENDOCRINE NEOPLASIA TYPE-2 | PLASMA METANEPHRINES | Pheochromocytoma - genetics | Pheochromocytoma - diagnosis | Pheochromocytoma - therapy | Humans | Causes of | Care and treatment | Pheochromocytoma | Diagnosis | Risk factors | Pathology | Adrenal glands | Medical treatment | Surgery | Diagnostic tests | Tumors
Journal Article
Best Practice & Research Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2011, Volume 26, Issue 4, pp. 507 - 515
Phaeochromocytomas and paragangliomas are neural crest-derived tumours. Autopsy studies indicate that relatively large numbers of these tumours remain...
Endocrinology & Metabolism | subclinical | catecholamines | susceptibility genes | incidentalomas | phaeochromocytoma | malignant | paraganglioma | GENE-MUTATIONS | SYMPATHETIC ACTIVITY | SUSCEPTIBILITY | ENDOCRINE NEOPLASIA TYPE-2 | IDENTIFICATION | SUCCINATE-DEHYDROGENASE | HEREDITARY | ENDOCRINOLOGY & METABOLISM | DOPAMINE | PARAGANGLIOMAS | RECEPTORS | Adrenal Gland Neoplasms - secretion | Catecholamines - secretion | Humans | Pheochromocytoma - pathology | Pheochromocytoma - genetics | Adrenal Gland Neoplasms - genetics | Adrenal Gland Neoplasms - pathology | Pheochromocytoma - secretion | Hypertension | Catecholamines | Disease susceptibility | Peptides | Tumors | Phaeochromocytoma
Endocrinology & Metabolism | subclinical | catecholamines | susceptibility genes | incidentalomas | phaeochromocytoma | malignant | paraganglioma | GENE-MUTATIONS | SYMPATHETIC ACTIVITY | SUSCEPTIBILITY | ENDOCRINE NEOPLASIA TYPE-2 | IDENTIFICATION | SUCCINATE-DEHYDROGENASE | HEREDITARY | ENDOCRINOLOGY & METABOLISM | DOPAMINE | PARAGANGLIOMAS | RECEPTORS | Adrenal Gland Neoplasms - secretion | Catecholamines - secretion | Humans | Pheochromocytoma - pathology | Pheochromocytoma - genetics | Adrenal Gland Neoplasms - genetics | Adrenal Gland Neoplasms - pathology | Pheochromocytoma - secretion | Hypertension | Catecholamines | Disease susceptibility | Peptides | Tumors | Phaeochromocytoma
Journal Article
Maturitas, ISSN 0378-5122, 2014, Volume 77, Issue 3, pp. 229 - 238
Abstract Pheochromocytomas are catecholamine producing neuroendocrine tumors that can be adrenal or extra-adrenal in origin. The classic symptoms of...
Internal Medicine | Obstetrics and Gynecology | Paraganglioma | Catecholamines | Pheochromocytoma | Adrenal gland | METASTATIC PHEOCHROMOCYTOMA | MANAGEMENT | HIPPEL-LINDAU-DISEASE | ENDOCRINE NEOPLASIA TYPE-2 | SECONDARY HYPERTENSION | CALCIUM-CHANNEL BLOCKERS | BIOCHEMICAL-DIAGNOSIS | GERIATRICS & GERONTOLOGY | OBSTETRICS & GYNECOLOGY | ADRENAL PHEOCHROMOCYTOMA | HEREDITARY PARAGANGLIOMA | NEUROFIBROMATOSIS TYPE-1 | Paraganglioma - therapy | Paraganglioma - genetics | Pheochromocytoma - diagnosis | Humans | Male | Paraganglioma - complications | Paraganglioma - diagnosis | Syndrome | Adrenal Gland Neoplasms - diagnosis | Pheochromocytoma - complications | Adrenal Gland Neoplasms - complications | Female | Pheochromocytoma - genetics | Mutation | Adrenal Gland Neoplasms - genetics | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - therapy | Catecholamines - genetics
Internal Medicine | Obstetrics and Gynecology | Paraganglioma | Catecholamines | Pheochromocytoma | Adrenal gland | METASTATIC PHEOCHROMOCYTOMA | MANAGEMENT | HIPPEL-LINDAU-DISEASE | ENDOCRINE NEOPLASIA TYPE-2 | SECONDARY HYPERTENSION | CALCIUM-CHANNEL BLOCKERS | BIOCHEMICAL-DIAGNOSIS | GERIATRICS & GERONTOLOGY | OBSTETRICS & GYNECOLOGY | ADRENAL PHEOCHROMOCYTOMA | HEREDITARY PARAGANGLIOMA | NEUROFIBROMATOSIS TYPE-1 | Paraganglioma - therapy | Paraganglioma - genetics | Pheochromocytoma - diagnosis | Humans | Male | Paraganglioma - complications | Paraganglioma - diagnosis | Syndrome | Adrenal Gland Neoplasms - diagnosis | Pheochromocytoma - complications | Adrenal Gland Neoplasms - complications | Female | Pheochromocytoma - genetics | Mutation | Adrenal Gland Neoplasms - genetics | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - therapy | Catecholamines - genetics
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2014, Volume 99, Issue 6, pp. 1915 - 1942
Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL). Participants: The Task Force included a chair...
POSITRON-EMISSION-TOMOGRAPHY | GENOTYPE-PHENOTYPE CORRELATIONS | HIPPEL-LINDAU-SYNDROME | ENDOCRINOLOGY & METABOLISM | TUMOR-SUPPRESSOR GENE | DIFFERENT HEREDITARY FORMS | PLASMA-FREE METANEPHRINES | TANDEM MASS-SPECTROMETRY | NON-SYNDROMIC PHEOCHROMOCYTOMA | CALCIUM-CHANNEL BLOCKERS | URINARY FREE METANEPHRINES | Diagnostic Techniques, Endocrine - standards | Paraganglioma - therapy | Precision Medicine - standards | Pheochromocytoma - diagnosis | Humans | Combined Modality Therapy | Paraganglioma - diagnosis | Evidence-Based Medicine | Diagnostic Imaging - standards | Consensus | Endocrinology - standards | Adrenal Gland Neoplasms - diagnosis | Diagnostic Imaging - methods | Adrenal Gland Neoplasms - epidemiology | Adrenalectomy - methods | Perioperative Care - methods | Perioperative Care - standards | Paraganglioma - epidemiology | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - therapy | Pheochromocytoma - epidemiology
POSITRON-EMISSION-TOMOGRAPHY | GENOTYPE-PHENOTYPE CORRELATIONS | HIPPEL-LINDAU-SYNDROME | ENDOCRINOLOGY & METABOLISM | TUMOR-SUPPRESSOR GENE | DIFFERENT HEREDITARY FORMS | PLASMA-FREE METANEPHRINES | TANDEM MASS-SPECTROMETRY | NON-SYNDROMIC PHEOCHROMOCYTOMA | CALCIUM-CHANNEL BLOCKERS | URINARY FREE METANEPHRINES | Diagnostic Techniques, Endocrine - standards | Paraganglioma - therapy | Precision Medicine - standards | Pheochromocytoma - diagnosis | Humans | Combined Modality Therapy | Paraganglioma - diagnosis | Evidence-Based Medicine | Diagnostic Imaging - standards | Consensus | Endocrinology - standards | Adrenal Gland Neoplasms - diagnosis | Diagnostic Imaging - methods | Adrenal Gland Neoplasms - epidemiology | Adrenalectomy - methods | Perioperative Care - methods | Perioperative Care - standards | Paraganglioma - epidemiology | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - therapy | Pheochromocytoma - epidemiology
Journal Article
Clinical chemistry, ISSN 0009-9147, 12/2014, Volume 60, Issue 12, pp. 1486 - 1499
BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are potentially lethal yet usually surgically curable causes of endocrine hypertension; therefore,...
FREE UNCONJUGATED METADRENALINES | ELECTROCHEMICAL DETECTION | LIQUID-CHROMATOGRAPHY | MULTIPLE ENDOCRINE NEOPLASIA | DIFFERENT HEREDITARY FORMS | FREE NORMETANEPHRINE | MEDICAL LABORATORY TECHNOLOGY | PLASMA-FREE METANEPHRINES | TANDEM MASS-SPECTROMETRY | BIOCHEMICAL-DIAGNOSIS | URINARY FREE METANEPHRINES | Clinical Laboratory Techniques | Pheochromocytoma - diagnosis | Humans | Adrenal Gland Neoplasms - blood | Dopamine - blood | Paraganglioma - diagnosis | Adrenal Gland Neoplasms - urine | Normetanephrine - blood | Paraganglioma - blood | Metanephrine - blood | Adrenal Gland Neoplasms - diagnosis | Dopamine - analogs & derivatives | Pheochromocytoma - blood | Pheochromocytoma | Medical examination | Diagnosis | Research | Analysis | Blood | Physiological aspects | Gliomas
FREE UNCONJUGATED METADRENALINES | ELECTROCHEMICAL DETECTION | LIQUID-CHROMATOGRAPHY | MULTIPLE ENDOCRINE NEOPLASIA | DIFFERENT HEREDITARY FORMS | FREE NORMETANEPHRINE | MEDICAL LABORATORY TECHNOLOGY | PLASMA-FREE METANEPHRINES | TANDEM MASS-SPECTROMETRY | BIOCHEMICAL-DIAGNOSIS | URINARY FREE METANEPHRINES | Clinical Laboratory Techniques | Pheochromocytoma - diagnosis | Humans | Adrenal Gland Neoplasms - blood | Dopamine - blood | Paraganglioma - diagnosis | Adrenal Gland Neoplasms - urine | Normetanephrine - blood | Paraganglioma - blood | Metanephrine - blood | Adrenal Gland Neoplasms - diagnosis | Dopamine - analogs & derivatives | Pheochromocytoma - blood | Pheochromocytoma | Medical examination | Diagnosis | Research | Analysis | Blood | Physiological aspects | Gliomas
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 10/2014, Volume 99, Issue 10, pp. E2046 - E2050
Context: At least a third of the patients with pheochromocytoma (PCC) or paraganglioma (PGL) harbor an underlying germline mutation in a known PCC/PGL gene....
FUMARATE HYDRATASE | MALIGNANT PHEOCHROMOCYTOMAS | GENE | PATHWAY | ENDOCRINOLOGY & METABOLISM | SUCCINATE | HEREDITARY LEIOMYOMATOSIS | PARAGANGLIOMA | CANCER | RENAL-CELL CARCINOMA | Paraganglioma - genetics | Humans | Middle Aged | Child, Preschool | Infant | Male | Fumarate Hydratase - genetics | Mutation, Missense | Young Adult | Adolescent | Age of Onset | Germ-Line Mutation | Female | Pheochromocytoma - genetics | Aged | Adrenal Gland Neoplasms - genetics | Child | Infant, Newborn
FUMARATE HYDRATASE | MALIGNANT PHEOCHROMOCYTOMAS | GENE | PATHWAY | ENDOCRINOLOGY & METABOLISM | SUCCINATE | HEREDITARY LEIOMYOMATOSIS | PARAGANGLIOMA | CANCER | RENAL-CELL CARCINOMA | Paraganglioma - genetics | Humans | Middle Aged | Child, Preschool | Infant | Male | Fumarate Hydratase - genetics | Mutation, Missense | Young Adult | Adolescent | Age of Onset | Germ-Line Mutation | Female | Pheochromocytoma - genetics | Aged | Adrenal Gland Neoplasms - genetics | Child | Infant, Newborn
Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 09/2015, Volume 45, Issue 9, pp. 986 - 997
Background Metastatic pheochromocytomas (PCs) and paragangliomas (PGLs) are rare neuroendocrine tumours with a strong genetic background. Design We searched...
temozolomide | Metastatic paragangliomas | metastatic pheochromocytomas | SDHB mutation | MIBG | Temozolomide | Metastatic pheochromocytomas | MEDICINE, RESEARCH & EXPERIMENTAL | LOCALIZATION | NEUROENDOCRINE TUMORS | EXTRAADRENAL PARAGANGLIOMAS | MAX MUTATIONS | MEDICINE, GENERAL & INTERNAL | HEREDITARY | MALIGNANT PHEOCHROMOCYTOMA | BENIGN | INHIBITOR SUNITINIB | EXPRESSION | ADRENAL PHEOCHROMOCYTOMAS | 3-Iodobenzylguanidine | Paraganglioma - therapy | Paraganglioma - genetics | Pheochromocytoma - diagnosis | Humans | Tomography, X-Ray Computed | Positron-Emission Tomography | Paraganglioma - diagnosis | Adrenal Gland Neoplasms - diagnosis | Multimodal Imaging | Paraganglioma - secondary | Succinate Dehydrogenase - genetics | Fluorodeoxyglucose F18 | Pheochromocytoma - genetics | Mutation | Pheochromocytoma - secondary | Radiopharmaceuticals | Adrenal Gland Neoplasms - genetics | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - pathology | Adrenal Gland Neoplasms - therapy | Chemotherapy | Metastasis | Cancer
temozolomide | Metastatic paragangliomas | metastatic pheochromocytomas | SDHB mutation | MIBG | Temozolomide | Metastatic pheochromocytomas | MEDICINE, RESEARCH & EXPERIMENTAL | LOCALIZATION | NEUROENDOCRINE TUMORS | EXTRAADRENAL PARAGANGLIOMAS | MAX MUTATIONS | MEDICINE, GENERAL & INTERNAL | HEREDITARY | MALIGNANT PHEOCHROMOCYTOMA | BENIGN | INHIBITOR SUNITINIB | EXPRESSION | ADRENAL PHEOCHROMOCYTOMAS | 3-Iodobenzylguanidine | Paraganglioma - therapy | Paraganglioma - genetics | Pheochromocytoma - diagnosis | Humans | Tomography, X-Ray Computed | Positron-Emission Tomography | Paraganglioma - diagnosis | Adrenal Gland Neoplasms - diagnosis | Multimodal Imaging | Paraganglioma - secondary | Succinate Dehydrogenase - genetics | Fluorodeoxyglucose F18 | Pheochromocytoma - genetics | Mutation | Pheochromocytoma - secondary | Radiopharmaceuticals | Adrenal Gland Neoplasms - genetics | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - pathology | Adrenal Gland Neoplasms - therapy | Chemotherapy | Metastasis | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2002, Volume 346, Issue 19, pp. 1459 - 1466
Germ-line mutations are common in familial glomus tumors, which include pheochromocytomas and paragangliomas. This study examined whether unsuspected germ-line...
MEDICINE, GENERAL & INTERNAL | HIPPEL-LINDAU DISEASE | HEREDITARY PARAGANGLIOMAS | TUMOR-SUPPRESSOR GENE | FAMILIAL PARAGANGLIOMA | ENDOCRINE NEOPLASIA TYPE-2 | MEDULLARY-THYROID CARCINOMA | COMPLEX-II GENE | VHL | SDHD | RET PROTOONCOGENE | Protein Subunits | Glomus Tumor - genetics | Humans | Ligases - genetics | Middle Aged | Child, Preschool | Iron-Sulfur Proteins - genetics | Male | Mutation, Missense | Electron Transport Complex II | Aged, 80 and over | Germ-Line Mutation | Adult | Female | Proto-Oncogene Proteins c-ret | Child | Drosophila Proteins | Oxidoreductases - genetics | Proto-Oncogene Proteins - genetics | Multienzyme Complexes - genetics | von Hippel-Lindau Disease - genetics | Ubiquitin-Protein Ligases | Succinate Dehydrogenase - genetics | Receptor Protein-Tyrosine Kinases - genetics | Adolescent | Age of Onset | Heterozygote | Pheochromocytoma - genetics | Aged | Von Hippel-Lindau Tumor Suppressor Protein | Multiple Endocrine Neoplasia Type 2a - genetics | Tumor Suppressor Proteins | Cohort Studies | Genetic aspects | Pheochromocytoma | Clinical trials | Mutation | Genes | Tumors
MEDICINE, GENERAL & INTERNAL | HIPPEL-LINDAU DISEASE | HEREDITARY PARAGANGLIOMAS | TUMOR-SUPPRESSOR GENE | FAMILIAL PARAGANGLIOMA | ENDOCRINE NEOPLASIA TYPE-2 | MEDULLARY-THYROID CARCINOMA | COMPLEX-II GENE | VHL | SDHD | RET PROTOONCOGENE | Protein Subunits | Glomus Tumor - genetics | Humans | Ligases - genetics | Middle Aged | Child, Preschool | Iron-Sulfur Proteins - genetics | Male | Mutation, Missense | Electron Transport Complex II | Aged, 80 and over | Germ-Line Mutation | Adult | Female | Proto-Oncogene Proteins c-ret | Child | Drosophila Proteins | Oxidoreductases - genetics | Proto-Oncogene Proteins - genetics | Multienzyme Complexes - genetics | von Hippel-Lindau Disease - genetics | Ubiquitin-Protein Ligases | Succinate Dehydrogenase - genetics | Receptor Protein-Tyrosine Kinases - genetics | Adolescent | Age of Onset | Heterozygote | Pheochromocytoma - genetics | Aged | Von Hippel-Lindau Tumor Suppressor Protein | Multiple Endocrine Neoplasia Type 2a - genetics | Tumor Suppressor Proteins | Cohort Studies | Genetic aspects | Pheochromocytoma | Clinical trials | Mutation | Genes | Tumors
Journal Article